nicotine has been researched along with liraglutide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
López, M | 1 |
Ashare, RL; Audrain-McGovern, J; Hayes, MR; Herman, RJ; Schmidt, HD | 1 |
Clemmensen, C; Dmytriyeva, O; Ejdrup, AL; Falk, S; Gether, U; Hecksher-Sørensen, J; Jørgensen, SH; Kohlmeier, KA; Krauth, N; Ludwig, MQ; Lundø, K; Nielsen, DAG; Pers, TH; Petersen, J; Romero-Leguizamón, CR; Roostalu, U; Skovbjerg, G; Svendsen, C | 1 |
1 review(s) available for nicotine and liraglutide
Article | Year |
---|---|
Hypothalamic AMPK and energy balance.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Antipsychotic Agents; Energy Metabolism; Feeding Behavior; Glucose; Homeostasis; Humans; Hypoglycemic Agents; Hypothalamus; Liraglutide; Liver; Metformin; Muscles; Nicotine; Nicotinic Agonists; Signal Transduction; Thermogenesis; Weight Gain | 2018 |
2 other study(ies) available for nicotine and liraglutide
Article | Year |
---|---|
Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats.
Topics: Animals; Extinction, Psychological; Female; Hyperphagia; Liraglutide; Male; Nicotine; Obesity; Rats; Self Administration; Tobacco Use Disorder | 2023 |
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity.
Topics: Animals; Dopamine; Glucagon-Like Peptide 1; Liraglutide; Mice; Nicotine; Obesity | 2023 |